Sunday, February 12, 2012

Asthma drugs get 'precaution' labeling

(Boston Globe) UPDATED 2009-06-16
The U.S. Food and Drug Administration (FDA) has requested that asthma drugs in the leukotriene receptor agonists category be given a "precaution" on the drugs' label. The drugs--which include Singulair, Accolate, and Zyflo--have garnered some complaints from patients regarding psychiatric side effects including insomnia, depression, agitation, and suicidal ideation. Safety reviews into the meds are ongoing, but in the meantime the FDA says patients and doctors should be aware of the risk of neuropsychiatric events associated with the medications.    Read full story >
See all Asthma News

People who read this also read...

  • Methylprednisolone Precautions
  • Diltiazem Precautions
  • Propranolol Precautions
  • Asthma Insomnia
  • Zyflo Cr 600 Mg
  • Chocolate Against Asthma